WO2002074922A3 - Compositions and methods for modulating an immune response - Google Patents
Compositions and methods for modulating an immune response Download PDFInfo
- Publication number
- WO2002074922A3 WO2002074922A3 PCT/US2002/008207 US0208207W WO02074922A3 WO 2002074922 A3 WO2002074922 A3 WO 2002074922A3 US 0208207 W US0208207 W US 0208207W WO 02074922 A3 WO02074922 A3 WO 02074922A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- immune response
- modulating
- compositions
- immunomodulatory nucleic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002248646A AU2002248646A1 (en) | 2001-03-16 | 2002-03-15 | Compositions and methods for modulating an immune response |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27686501P | 2001-03-16 | 2001-03-16 | |
US60/276,865 | 2001-03-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074922A2 WO2002074922A2 (en) | 2002-09-26 |
WO2002074922A3 true WO2002074922A3 (en) | 2003-02-20 |
Family
ID=23058390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/008207 WO2002074922A2 (en) | 2001-03-16 | 2002-03-15 | Compositions and methods for modulating an immune response |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002248646A1 (en) |
WO (1) | WO2002074922A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9028845B2 (en) | 2001-06-21 | 2015-05-12 | Dynavax Technologies Corporation | Chimeric immunomodulatory compounds and methods of using the same-IV |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69932717T2 (en) | 1998-05-22 | 2007-08-09 | Ottawa Health Research Institute, Ottawa | METHODS AND PRODUCTS FOR INDUCING MUCOSAL IMMUNITY |
US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
SG173219A1 (en) | 2002-12-23 | 2011-08-29 | Dynavax Tech Corp | Immunostimulatory sequence oligonucleotides and methods of using the same |
-
2002
- 2002-03-15 WO PCT/US2002/008207 patent/WO2002074922A2/en not_active Application Discontinuation
- 2002-03-15 AU AU2002248646A patent/AU2002248646A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
KAY ET AL.: "Allergic diseases and their treatment", N. ENGL. J. MED., vol. 344, no. 2, 11 January 2001 (2001-01-11), pages 109 - 113 * |
SEREBRISKY ET AL.: "CpG oligonucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma", J. OF IMMUNOL., vol. 165, no. 10, 2000, pages 5906 - 5912 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9028845B2 (en) | 2001-06-21 | 2015-05-12 | Dynavax Technologies Corporation | Chimeric immunomodulatory compounds and methods of using the same-IV |
Also Published As
Publication number | Publication date |
---|---|
WO2002074922A2 (en) | 2002-09-26 |
AU2002248646A1 (en) | 2002-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1458395A (en) | Composition containing nucleic acids, preparation and uses | |
WO2003028757A1 (en) | Novel method of inducing antigen-specific t cells | |
WO1998055495A3 (en) | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof | |
CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
RS50325B (en) | Immunostimulatory nucleic acids | |
ATE355826T1 (en) | METHOD FOR ENCAPSULATING NUCLEIC ACIDS IN LIPID DOUBLE LAYERS | |
WO2002094210A3 (en) | Cosmetic agents | |
WO2003045427A3 (en) | Pharmaceutical composition for inducing an immune response in a human or animal | |
CA2169297A1 (en) | Protein- or peptide-cochleate vaccines and methods of immunizing using the same | |
AU2002243005A1 (en) | Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods | |
WO2000015179A3 (en) | Cosmetic composition | |
WO2001081609A3 (en) | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems | |
AU4846690A (en) | Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament | |
WO1999032634A3 (en) | Compositions derived from mycobacterium vaccae and methods for their use | |
CA2368165A1 (en) | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases | |
EP1344515A4 (en) | Skin cosmetics | |
PH31320A (en) | Fenbendazole formulations. | |
WO1999024077A3 (en) | Compositions and methods for targeted delivery of biologically-active factors | |
WO2002074922A3 (en) | Compositions and methods for modulating an immune response | |
BG101379A (en) | New pypimido [1,2-a] indoles | |
WO2002034287A3 (en) | Therapeutic vaccine formulations containing chitosan | |
IL111152A0 (en) | Retinoic acid esters, their preparation and pharmaceutical or cosmetic compositions containing them | |
WO1999049876A3 (en) | Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof | |
SI1196129T1 (en) | Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants | |
WO2006031786A3 (en) | Protein a compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |